The company has appointed Mr Christian Johnson as its Vice President, North America. Mr Johnson a seasoned sports industry executive was previously Vice President, Sales for GU Energy Labs, a high-growth, category leading, global sports nutrition brand.
The first six months of the financial year saw Rhinomed Ltd (ASX:RNO) consolidate its move into the sport market with its inaugural technology, Turbine, which was launched in January 2014. Our strategy is to use Australia as a test market before taking our branded technology to global markets.
Leading Australia-based medical device company, Compumedics Limited (ASX:CMP) is pleased to announce profitability and revenue growth for the half year ending 31 December 2014.
Regenerative medicine company, Regeneus Ltd (ASX:RGS) is pleased to announce the appointment of Dr Glen Richards as an independent non-executive director of Regeneus with effect from April.
Regenerative medicine company, Regeneus Ltd (ASX:RGS), today reported its financial results for the half-year ended 31 December 2014.
Regeneus Ltd (ASX:RGS) Regeneus Half-Yearly Appendix 4D and Accounts. Following is the review of operations for the period.
On the 2 April 2014, Reproductive Health Science Ltd (ASX:RHS) successfully completed the acquisition of Reproductive Health Science Pty Ltd (now RHS Subsidiary Pty Ltd, 'RHS Subsidiary '), resulting in the issue of 19,120,704 fully paid shares in the Company.
